Literature DB >> 25253100

The Warburg effect: molecular aspects and therapeutic possibilities.

Hanh Ngo1, Stephanie M Tortorella, Katherine Ververis, Tom C Karagiannis.   

Abstract

It has been about nine decades since the proposal of Otto Warburg on the metabolism of cancer cells. Unlike normal cells which undergo glycolysis and oxidative phosphorylation in the presence of oxygen, proliferating and cancer cells exhibit an increased uptake of glucose and increased rate of glycolysis and predominantly undergo lactic acid fermentation. Whether this phenomenon is the consequence of genetic dysregulation in cancer or is the cause of cancer still remains unknown. However, there is certainly a strong link between the genetic factors, epigenetic modulation, cancer immunosurveillance and the Warburg effect, which will be discussed in this review. Dichloroacetate and 3-bromopyruvate are among the substances that have been studied as potential cancer therapies. With our expanding knowledge of cellular metabolism, therapies targeting the Warburg effect appear very promising. This review discusses different aspects of these emerging therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25253100     DOI: 10.1007/s11033-014-3764-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  83 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.

Authors:  Seyma Charni; Geoffroy de Bettignies; Moeez G Rathore; Juan I Aguiló; Peter J van den Elsen; Delphine Haouzi; Robert A Hipskind; José Antonio Enriquez; Margarita Sanchez-Beato; Julián Pardo; Alberto Anel; Martin Villalba
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

3.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  Dichloroacetate in the treatment of lactic acidosis.

Authors:  P W Stacpoole; A C Lorenz; R G Thomas; E M Harman
Journal:  Ann Intern Med       Date:  1988-01       Impact factor: 25.391

6.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

7.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

Authors:  V M Richon; T W Sandhoff; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Authors:  Peter L Pedersen; Saroj Mathupala; Annette Rempel; J F Geschwind; Young Hee Ko
Journal:  Biochim Biophys Acta       Date:  2002-09-10

Review 9.  Metabolic defects provide a spark for the epigenetic switch in cancer.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

Review 10.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

View more
  37 in total

1.  177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study.

Authors:  Giovanni Paganelli; Maddalena Sansovini; Silvia Nicolini; Ilaria Grassi; Toni Ibrahim; Elena Amadori; Valentina Di Iorio; Manuela Monti; Emanuela Scarpi; Alberto Bongiovanni; Mattia Altini; Luca Urso; Corrado Cittanti; Federica Matteucci; Stefano Severi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-29       Impact factor: 9.236

2.  Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.

Authors:  Yang Yu; Xiaohui Yu; Chenling Fan; Hong Wang; Renee Wang; Chen Feng; Haixia Guan
Journal:  J Mol Med (Berl)       Date:  2018-06-25       Impact factor: 4.599

3.  Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE.

Authors:  Maddalena Sansovini; Stefano Severi; Annarita Ianniello; Silvia Nicolini; Lorenzo Fantini; Emilio Mezzenga; Fabio Ferroni; Emanuela Scarpi; Manuela Monti; Alberto Bongiovanni; Sara Cingarlini; Chiara Maria Grana; Lisa Bodei; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-04       Impact factor: 9.236

Review 4.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

5.  Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.

Authors:  Raquel Palao-Suay; María Rosa Aguilar; Francisco J Parra-Ruiz; Sergio Martín-Saldaña; Nathan A Rohner; Susan N Thomas; Julio San Román
Journal:  J Mater Sci Mater Med       Date:  2017-08-31       Impact factor: 3.896

6.  Metabolic Reprogramming Promotes Neural Crest Migration via Yap/Tead Signaling.

Authors:  Debadrita Bhattacharya; Ana Paula Azambuja; Marcos Simoes-Costa
Journal:  Dev Cell       Date:  2020-04-02       Impact factor: 12.270

Review 7.  Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease.

Authors:  Chris Cadonic; Mohammad Golam Sabbir; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

8.  The NAD(+) salvage pathway modulates cancer cell viability via p73.

Authors:  T Sharif; D-G Ahn; R-Z Liu; E Pringle; E Martell; C Dai; A Nunokawa; M Kwak; D Clements; J P Murphy; C Dean; P Marcato; C McCormick; R Godbout; S A Gujar; P W K Lee
Journal:  Cell Death Differ       Date:  2015-11-20       Impact factor: 15.828

9.  Lactate Exposure Promotes Immunosuppressive Phenotypes in Innate Immune Cells.

Authors:  Rapeepat Sangsuwan; Bhasirie Thuamsang; Noah Pacifici; Riley Allen; Hyunsoo Han; Svetlana Miakicheva; Jamal S Lewis
Journal:  Cell Mol Bioeng       Date:  2020-09-21       Impact factor: 2.321

10.  Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells.

Authors:  Ana Sofia Rodrigues; Sandro L Pereira; Marcelo Correia; Andreia Gomes; Tânia Perestrelo; João Ramalho-Santos
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.